Markets › India › NSE › RUBICON

Rubicon Research Ltd

NSE:RUBICONHealth TechnologyNSE:CNX500NSE:NIFTY500_EW

₹1,486.70−1.45%At closeAt close · Mon 19 Oct · ≈ AED 57.36 · Market cap $2.53B · Next earnings Wed 2 Dec

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	26.8%	26.8%	26.4%	41.4%	45.7%	46.8%	+1.1 pts
Operating margin	—	−24.5%	−4.7%	13.4%	16.6%	20.0%	+3.4 pts
Net margin	−21.6%	−21.6%	−4.3%	10.7%	10.5%	14.1%	+3.6 pts
EBITDA margin	−13.5%	−13.5%	4.6%	18.0%	19.5%	22.6%	+3.1 pts
Return on equity	—	−22.0%	−5.9%	23.6%	24.8%	19.1%	−5.7 pts
Return on assets	−12.0%	−12.0%	−2.3%	8.2%	9.3%	10.6%	+1.3 pts
Return on capital employed	—	−20.2%	−4.7%	21.2%	31.8%	23.4%	−8.4 pts
Debt / equity	—	0.6×	1.1×	1.1×	0.8×	0.2×	−68.7%
Debt / assets	31.3%	31.3%	42.6%	39.8%	28.8%	13.4%	−15.4 pts
Interest coverage	0.0×	−7.8×	−1.0×	3.8×	6.4×	8.5×	+32.4%
Current ratio	—	1.8×	1.4×	1.3×	1.4×	2.0×	+48.7%
Quick ratio	—	1.3×	0.9×	0.8×	0.7×	1.1×	+64.9%
Cash ratio	—	0.3×	0.2×	0.1×	0.1×	0.2×	+50.2%
Asset turnover	0.6×	0.6×	0.5×	0.8×	0.9×	0.8×	−14.5%
Inventory turnover	—	2.5×	1.7×	1.6×	1.3×	1.2×	−4.7%
Receivables turnover	—	2.1×	1.7×	2.8×	3.8×	3.2×	−16.8%
Dividend payout	—	−0.8%	−1.5%	0.3%	0.2%	0.1%	−0.1 pts